RNS Number : 1401T
Spectra Systems Corporation
15 July 2020
Spectra Systems Corporation
("Spectra Systems" or the "Company")
Director Dealings
Spectra Systems announces that on 14 July 2020, Donald Stanford, Non-executive Director of the Company, sold 35,670 shares of common stock of $0.01 in the Company ("Shares").
Enquiries:
Spectra Systems Corporation
Dr. Nabil Lawandy, Chief Executive Officer Tel: +1 (0) 401 274 4700
WH Ireland Limited
Chris Fielding (
Managing Director, Corporate Finance
) Tel: +44 (0) 20 7220 1650
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1
|
Details of the person discharging managerial responsibilities/person closely associated
|
|
a)
|
Name
|
Donald Stanford
|
|
2
|
Reason for the notification
|
|
a)
|
Position/status
|
Non-executive Director
|
|
b)
|
Initial notification/ Amendment
|
Initial Notification
|
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|
a)
|
Name
|
Spectra Systems Corporation
|
|
b)
|
LEI
|
21380047EWJYQG53D640
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial instrument, type of instrument
Identification code
|
Common stock of US$0.01
ISIN:
US84756T1060
TIDM: SPSY
|
|
b)
|
Nature of the transaction
|
Sale of Shares
|
|
c)
|
Price(s) and volume(s)
|
|
Price(s)
|
Volume(s)
|
|
120.00
|
15,670
|
|
120.00
|
20,000
|
|
|
d)
|
Aggregated information
-
Aggregated volume
-
Price
|
35,670
120.00
|
|
e)
|
Date of the transaction
|
14 July 2020
|
|
f)
|
Place of the transaction
|
London Stock Exchange
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
DSHKKPBBOBKDNOD